Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://figshare.com/articles/dataset/Optimization_of_Orally_Bioavailable_PI3K_Inhibitors_and_Identification_of_Vps34_as_a_Key_Selectivity_Target/11550393
下载链接
链接失效反馈官方服务：
资源简介：
Optimization
of a lead series of PI3Kδ inhibitors based on
a dihydroisobenzofuran core led to the identification of potent, orally
bioavailable compound 19. Selectivity profiling of compound 19 showed similar potency for class III PI3K, Vps34, and PI3Kδ,
and compound 19 was not well-tolerated in a 7-day rat
toxicity study. Structure-based design led to an improvement in selectivity
for PI3Kδ over Vps34 and, a focus on oral phramacokinetics properties
resulted in the discovery of compound 41, which showed
improved toxicological outcomes at similar exposure levels to compound 19.
创建时间：
2019-12-19
